Authors


Susana Da Silva, MSc

Latest:

Negative Symptoms in Schizophrenia: Etiology, Hypotheses, and Treatment Implications

Negative symptoms are prominent in schizophrenia. Despite their importance in driving functional outcomes, however, effective treatment of negative symptoms remains elusive.


Sarah Saperia

Latest:

Negative Symptoms in Schizophrenia: Etiology, Hypotheses, and Treatment Implications

Negative symptoms are prominent in schizophrenia. Despite their importance in driving functional outcomes, however, effective treatment of negative symptoms remains elusive.


Gary Remington, MD, PhD

Latest:

Negative Symptoms in Schizophrenia: Etiology, Hypotheses, and Treatment Implications

Negative symptoms are prominent in schizophrenia. Despite their importance in driving functional outcomes, however, effective treatment of negative symptoms remains elusive.


George Foussias, MD, PhD

Latest:

Negative Symptoms in Schizophrenia: Etiology, Hypotheses, and Treatment Implications

Negative symptoms are prominent in schizophrenia. Despite their importance in driving functional outcomes, however, effective treatment of negative symptoms remains elusive.


Liza Hoffman, LICSW

Latest:

Smartphone Apps for Serious Mental Illness: A Step-by-Step Tutorial to Help You Support Your Patients

You don’t need to be a tech wizard to help patients and offer guidance on digital mental health tools.


Michael A. Kalm, MD

Latest:

How a Biden Green New Deal Will Affect Our Patients and What We Can Do to Help

Resistance to climate change often comes from the same place: denial.


Bruce I. Goderez, MD

Latest:

Making Sense of Meditation: Religion and Spirituality

You would think that psychiatrists are well-versed in religion and spirituality, but the reality is that they are barely touched upon during our training.


Suzanne Vogel-Scibilia, MD

Latest:

Assisting Ukraine With Tinkerbell and Friends

“When faced with senseless violence in a distant, war-torn place, our actions help our colleagues on the medical front lines.”


Brynn S. Chavira

Latest:

Should We Prescribe Different Dosages of Psychotropic Medications to Men and Women?

Finding the right dosage of a psychotropic may be notoriously time consuming, but thought should be granted to the sexually dimorphic expression of CYP450 enzymes when prescribing medication. 


Elham Rahmani, MD, MPH

Latest:

Should We Prescribe Different Dosages of Psychotropic Medications to Men and Women?

Finding the right dosage of a psychotropic may be notoriously time consuming, but thought should be granted to the sexually dimorphic expression of CYP450 enzymes when prescribing medication. 


Janet Charoensook, MD

Latest:

Introduction to Immunotherapy of Malignancies for Psychiatrists

There has been significant improvement in the outcome of many malignancies, which have required balancing anti-tumor immunity and immune toxicity.


Susan Turkel, MD

Latest:

Introduction to Immunotherapy of Malignancies for Psychiatrists

There has been significant improvement in the outcome of many malignancies, which have required balancing anti-tumor immunity and immune toxicity.


Marie E. Gehle, PsyD

Latest:

The Role of Social Media in Private Practice

The challenges of using social media can be as numerous as the benefits.


Climate Psychiatry Alliance

Latest:

It Takes a Village to Take Care of a Planet

All together, right now, no matter what it takes-only this attitude can unite our response to the climate catastrophe that is the imminent consequence of our many small everyday actions.


Bridianne O’Dea, PhD

Latest:

Digital Mental Health: How to Engage With Innovation, Part 1

How safe and effective are mental health apps? What’s the impact of social media on youth? Insights here from presenters at APA 2019.


Mark Larsen, PhD

Latest:

Digital Mental Health: How to Engage With Innovation, Part 1

How safe and effective are mental health apps? What’s the impact of social media on youth? Insights here from presenters at APA 2019.


Julien Epps, PhD

Latest:

Digital Mental Health: How to Engage With Innovation, Part 2

Among the innovations presented at the 2019 APA meeting: voice analytics for detecting and monitoring mood, and smartphone and web-based passive data as a digital biomarker for mental health disorders.


Abhishek Pratap

Latest:

Digital Mental Health: How to Engage With Innovation, Part 2

Among the innovations presented at the 2019 APA meeting: voice analytics for detecting and monitoring mood, and smartphone and web-based passive data as a digital biomarker for mental health disorders.


Karen B. Rosenbaum, MD

Latest:

Nine Perfect Strangers

Microdosing at “Tranquillum House,” and its implications for real-world experimental psychopharmacology.


Daniel Morehead, MD

Latest:

The Power of Plain Old Psychiatry

Patients should be confident about what psychiatric care offers, regardless of whether they utilize any specific treatments, or even recognize that they are receiving therapeutic care.


Jessica Isom, MD, MPH

Latest:

Recognizing the Black Psychiatrists of Yesterday, Today, and Tomorrow

“The contributions of Black psychiatrists are essential for us achieving the work, achieving our goals, and really leaning into what we find to be our ‘why’ for why we do this work.”


Balkozar S. Adam, MD

Latest:

Black Americans’ Distrust of the COVID-19 Vaccine

A case for why psychiatrists should discuss the COVID vaccines with their patients.


Eleanor Lastrapes, MD

Latest:

The Aftermath of School Shootings

The impact of school shootings extends far beyond the directly affected school and community. What can we do to help survivors and family members?


Anca Livia Panfil, MD

Latest:

Ophelia

She was only 21. After "it" happened, I held a lecture on depression. I mentioned her at the end as a tribute. I longed for closure. More in this Portrait of a Psychiatrist.


Cornel N. Stanciu, MD, MRO

Latest:

Reducing Opioid-Involved Overdose Deaths: States’ Prevention and Response Efforts

In this journal club, a medical student and an addiction psychiatrist review a thematic analysis of successful prevention efforts in states with declining rates of opioid-related overdose deaths.


Samantha A. Gnanasegaram, MD

Latest:

Adjunctive Atypical Antipsychotics in Major Depressive Disorder: What’s the Impact?

The authors explore adjunctive treatments for MDD and their impact on overall medical costs and health care utilization.


Thomas M. Penders, MS, MD

Latest:

Medication-Assisted Treatment on a Budget: Two You Should Know

This CME discusses the opioid-like effects of loperamide and kratom and raises awareness of potential dangers associated with use.


Stephanie Liddicoat, PhD

Latest:

Strategies to Facilitate a Positive Clinical Encounter

The counseling environment is regarded within clinical literature as having an effect on a patient’s sense of well-being.


Aditya Vaidyam, MS

Latest:

Chatbots: What Are They and Why Care?

While conversational agent technology is growing rapidly, the various technologies (chatbots) might not yet be fully equipped to help patients with clinical needs.


Sidra Qadir, MD

Latest:

Treating Patients With Comorbid Anxiety and Diabetes Mellitus

Anxiety disorders are highly prevalent in the general population, particularly in those with medical illnesses such as diabetes.

© 2024 MJH Life Sciences

All rights reserved.